M&A

Debt-laden Takeda to sell OTC drugs in Middle East and Africa for $200m
Debt-laden Takeda to sell OTC drugs in Middle East and Africa for $200m
Pharmaforum
Takeda
Shire
M&A
Acino
Middle East
Africa
Flag link:
BridgeBio scraps plan to buy Eidos after bids rebuffed
BridgeBio scraps plan to buy Eidos after bids rebuffed
Fierce Biotech
BridgeBio
Edios Therapeutics
M&A
Flag link:
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Motley Fool
biotech
IPOs
M&A
Flag link:
AbbVie Stays Busy While Working to Complete Allergan Acquisition
AbbVie Stays Busy While Working to Complete Allergan Acquisition
BioSpace
AbbVie
Allergan
M&A
Skyrizi
Reata Pharmaceuticals
Flag link:
UCB strikes $2.5B deal to buy Ra for rival to Alexion's Soliris
UCB strikes $2.5B deal to buy Ra for rival to Alexion's Soliris
Fierce Biotech
UCB Pharma
Ra Pharmaceuticals
M&A
zilucoplan
Alexion
Soliris
Flag link:
Takeda breaks into top 20 largest pharmas with Shire merger
Takeda breaks into top 20 largest pharmas with Shire merger
Pharmaforum
Takeda
Shire
M&A
Flag link:
Pharma, Biotech VC Investments Continue Shift to Early Stage Deals
Pharma, Biotech VC Investments Continue Shift to Early Stage Deals
Xconomy
venture capital
M&A
Flag link:
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
M&A
Lundbeck
Alder Biopharmaceuticals
Gilead Sciences
Galapagos
Vertex Pharmaceuticals
Semma
Swedish Orphan Biovitrum
Dova Pharmaceuticals
Novartis
IFM
Flag link:
M&A Will Continue to Be a Mainstay for Growth in the Pharma Industry
M&A Will Continue to Be a Mainstay for Growth in the Pharma Industry
BioSpace
M&A
Flag link:
Veeva acquires Crossix, pairing doctor, patient data and marketing services
Veeva acquires Crossix, pairing doctor, patient data and marketing services
Fierce Pharma
Veeva
Crossix Solutions
Veeva Crossix
patient data
physicians
M&A
Flag link:
Immunovant set to land on Nasdaq via HSAC merger
Immunovant set to land on Nasdaq via HSAC merger
Fierce Biotech
Immunovant
NASDAQ
M&A
Health Sciences Acquisitions Corporation
Flag link:
Servier acquires lymphoma drug Pixuvri from CTI BioPharma
Servier acquires lymphoma drug Pixuvri from CTI BioPharma
Pharmaceutical Business Review
Pixuvri
Servier
CTI BioPharma
M&A
lymphoma
Flag link:
Dova Pharma's bet on Eisai castoff spells gold as Sobi spends millions to acquire it
Dova Pharma's bet on Eisai castoff spells gold as Sobi spends millions to acquire it
Endpoints
Dova Pharmaceuticals
Eisai
Swedish Orphan Biovitrum
M&A
Flag link:
Roche sets new deadline for Spark acquisition as divestiture speculation brews
Roche sets new deadline for Spark acquisition as divestiture speculation brews
Endpoints
Roche
Spark Therapeutics
M&A
Flag link:
FTC requests AbbVie, Allergan for more information on $63 billion deal
FTC requests AbbVie, Allergan for more information on $63 billion deal
Reuters
FTC
M&A
AbbVie
Allergan
Flag link:
As Celgene becomes BMS, its I&I lead lands CEO job at Takeda spinoff
As Celgene becomes BMS, its I&I lead lands CEO job at Takeda spinoff
Fierce Biotech
Celgene
Bristol-Myers Squibb
M&A
Terrie Curran
Phathom
Flag link:
Anthem To Buy Divested Centene-WellCare Medicaid Plans In Two States
Anthem To Buy Divested Centene-WellCare Medicaid Plans In Two States
Forbes
Anthem
M&A
WellCare
Missouri
Nebraska
Centene
Flag link:
Takeda eyes emerging markets asset sale to trim its debt; report
Takeda eyes emerging markets asset sale to trim its debt; report
Pharmaforum
Takeda
Shire
M&A
emerging markets
Europe
Flag link:
Roche-Spark deal review in U.K. unnerves M&A watchers—and they were spooked already
Roche-Spark deal review in U.K. unnerves M&A watchers—and they were spooked already
Fierce Pharma
M&A
UK
Spark Therapeutics
Roche
antitrust
CMA
Flag link:
Amryt buys Aegerion via bankruptcy, adding sales to support R&D
Amryt buys Aegerion via bankruptcy, adding sales to support R&D
Fierce Biotech
Amryt Pharma
Aegerion
M&A
R&D
bankruptcy
AP101
Flag link:

Pages